At JP Morgan conference, health care investors gear up for transformative legal developments
Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal developments impacting health care delivery that will be top of mind for investors at the JP Morgan Healthcare Conference.
This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...
Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...
SAN FRANCISCO - The J.P. Morgan Healthcare Conference kicked off in San Francisco's Union Square on Monday. The conference drew an estimated 8,000 attendees to the Westin St. Francis. Mayor Daniel ...
Sanofi (SYN) 43rd Annual J.P. Morgan Healthcare January 14, 2025 12:45 PM ETCompany ParticipantsPaul Hudson - Chief Executive OfficerFrancois-Xavier Roger ...
The JP Morgan Healthcare Conference will show us many examples of how AI is affecting Healthcare. Cerebras and Nvidia are ...
Oral Presentation Presented at ASH 2024 Showed Iopofosine I 131 Achieved an 83.6% ORR and Exceeded Primary and Secondary ...
J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers ...
Industry leaders from more than 500 companies scheduled to give investor presentations will see heightened security ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback